Characterisation of xenobiotic-metabolising enzyme expression in human bronchial mucosa and peripheral lung tissues

European Journal of Cancer

Volumn 34, Issue 6, 1998, Pages 914-920

  Mace K ^a,b   Bowman, E D ^a,b   Vautravers, P ^a,b   Shields, P G ^a,b   Harris, C C ^a,b   Pfeifer, A M A ^a,b  

^a NESTLÉ RESEARCH CENTER   (Switzerland)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Carcinogens; Cytochrome P450; Gene expression; Lung; Phase I enzymes; Phase II enzymes

Indexed keywords

ACYLTRANSFERASE; CYTOCHROME; CYTOCHROME P1A1; CYTOCHROME P2C; GLUTATHIONE TRANSFERASE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; BRONCHUS MUCOSA; CANCER SUSCEPTIBILITY; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ASSAY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG CANCER; LUNG TOXICITY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESPIRATORY EPITHELIUM; TISSUE SPECIFICITY; XENOBIOTIC METABOLISM;

ADOLESCENT; ADULT; AGED; BRONCHI; CELL LINE; CYTOCHROME P-450 ENZYME SYSTEM; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; LUNG; MALE; MIDDLE AGED; MUCOUS MEMBRANE; POLYMERASE CHAIN REACTION; RNA, MESSENGER; SUBSTRATE SPECIFICITY; XENOBIOTICS;

EID: 0032077398     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(98)00034-3     Document Type: Article

References (27)

1. Harris CC. Interindividual variations among humans in carcinogen metabolism, DNA adduct formation and DNA repair. Carcinogenesis 1989, 10, 1563-1566.
2. Weinstein IB, Jeffrey AM, Jennette KW, et al. Benzo(a)pyrene diol epoxides as intermediates in nucleic acid binding. Science 1976, 193, 592-595.
3. Harris CC, Autrup H, Stoner GD, McDowell EM, Trump BF, Schafer P. Metabolism of dimethylnitrosamine and 1,2-dimethylhydrazine in cultured human bronchi. Cancer Res 1977, 37, 2309-2311.
4. Stoner GD, Harris CC, Autrup H, Trump BF, Kingsbury EW, Myers GA. Expiant culture of human peripheral lung: metabolism of benzo(a)pyrene. Lab Invest 1978, 38, 685-692.
5. Wheeler CW, Wrighton SA, Guenthner TM. Detection of human lung cytochromes P450 that are immunochemically related to cytochrome P450IIE1 and cytochrome P450IIIA. Biochem Pharmacol 1992, 44, 183-186.
6. Shimada T, Yamazaki H, Mimura M, et al. Characterization of microsomal cytochrome P450 enzymes involved in the oxidation of xenobiotic chemicals in human fetal livers and adult lungs. Drug Metab Dispos 1996, 25, 515-522.
7. Reddel RR, Ke Y, Gerwin BI, et al. Transformation of human bronchial epithelial cells by infection with SV40 or adenovirus12 SV40 hybrid virus, or transfection via strontium phosphate coprecipitation with a plasmid containing SV40 early region genes. Cancer Res 1988, 48, 1904-1909.
8. Lechner JF, La Veck MA. A serum-free method for culturing normal human bronchial epithelial cells at clonal density. J Tissue Culture Meth 1985, 9, 43-48.
9. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thyocyanate-phenol-chloroform extraction. Anal Biochem 1987, 162, 156-159.
10. Macé K, Vautravers P, Granato D, Gonzalez FJ, Harris CG, Pfeifer AMA. Development of CYP450-expressing human bronchial epithelial cell lines for in vitro pharmacotoxicological applications. In Vitro Toxicol 1997, 10, 86-92.
11. Macé K, Gonzalez FJ, McConnell IR, et al. Activation of promutagens in a human bronchial epithelial cell line stably expressing human cytochrome P450 1A2. Mol Carcinog 1994, 11, 65-73.
12. Pottenger LH, Jefcoate CR. Characterization of a novel cytochrome P450 from the transformable cell line, C3H/10T1/2. Carcinogenesis 1990, 11, 321-327.
13. Macé K, Offord EA, Pfeifer AMA. Drug metabolism and carcinogen activation studies with human genetically engineered cells. In Castell JV, Gomez-Lechon MJ, eds. In Vitro Methods in Pharmaceutical Research. London, Academic Press, 1997, 433-456.
14. Yamano S, Nhamburo PT, Aoyama T, et al. cDNA cloning and sequence and cDNA-directed expression of human P450 IIB1: identification of a normal and two variant cDNAs derived from the CYP2B locus on chromosome 19 and differential expression of the IIB mRNAs in human liver. Biochemistry 1989, 28, 7340-7348.
15. McLemore TL, Adelberg S, Liu MC, et al. Expression of CYP4501A1 gene in patients with lung cancer: evidence for cigarette smoke-induced gene expression in normal lung tissue and for altered gene regulation in primary pulmonary carcinomas. J Natl Cancer Inst 1990, 82, 1333-1339.
16. Toussaint C, Albin N, Massaad L, et al. Main drug- and carcinogen-metabolizing enzyme systems in human non-small cell lung cancer and peritumoral tissues. Cancer Res 1993, 53, 4608-4612.
17. Gonzalez FJ. Human cytochromes P450: problems and prospects. TiPS 1992, 13, 346-352.
18. Gordon T, Amdur MO. Responses of the respiratory system to toxic agents. In Amdur MO, Doull J, Klaassen CD, eds. Casarett and Doutt's Toxicology: the Basic Science of Poisons. New York, McGraw-Hill, 1993, 383-406.
19. Anttila S, Hietanen E, Vainio H, et al. Smoking and peripheral type of cancer are related to high levels of pulmonary cytochrome P450IAin lung cancer patients. Int J Cancer 1991, 47, 681-685.
20. Farin FM, Pohlman TH, Omiecinski CJ. Expression of cytochrome P450s and microsomal epoxide hydrolase in primary cultures of human umbilical vein endothelial cells. Toxicol Appl Pharmacol 1994, 124, 1-9.
21. Kivisto KT, Fritz P, Linder A, Friedel G, Beaune P, Kroemer HK. Immunohistochemical localization of cytochrome P450 3A in human pulmonary carcinomas and normal bronchial tissue. Histochemistry 1995, 103, 25-29.
22. Anttila S, Hukkanen J, Hakkola J, et al. Expression and localization of CYP3A4 and CYP3A5 in human lung. Am J Respir Cell MolBiol 1997, 16, 242-249.
23. Bellec G, Dreano Y, Lozach P, Menez JF, Berthou F. Cytochrome P450 metabolic dealkylation of nine N-nitrosodialkylamines. Carcinogenesis 1996, 17, 2029-2034.
24. Gonzalez FJ, Crespi CL, Czerwinski M, Gelboin HV. Analysis of human cytochrome P450 catalytic activities and expression. Tohoku J Exp Med 1992, 168, 67-72.
25. Smith CAD, Smith G, Wolf CR. Genetic polymorphisms in xenobiotic metabolism. Eur J Cancer 1994, 30A, 1921-1935.
26. Bouchardy C, Benhamou S, Dayer P. The effect of tobacco on lung cancer risk depends on CYP2D6 activity. Cancer Res 1996, 56,251-253.
27. Board P, Coggan M, Johnston P, Ross V, Suzuki T, Webb G. Genetic heterogeneity of the human glutathione transferases: a complex of gene families. Pharmacol Ther 1990, 48, 357-369.